Ysios Capital’s portfolio company Aura Biosciences prices IPO on NASDAQ

by Ysios Capital

Ysios Capital, a leading Spanish biotechnology venture capital firm, has announced that its portfolio company Aura Biosciences Inc. has priced its initial public offering (IPO) and is trading on the N...

Read more

Aura Biosciences sale a bolsa en el NASDAQ

by Columbus Venture Partners

Columbus Venture Partners ha apoyado a la compañía desde la serie B, a través de su fondo Columbus INNVIERTE Life Science FCR, así como en la serie «pre OPS» que tuvo lugar en marzo de 2021 y en...

Read more

Aura Biosciences, supported by Ysios Capital, Announces Oversubscribed $80 Million Financing

by Ysios Capital

Aura Biosciences, a clinical-stage oncology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the closing of an oversubsc...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

tuTECHÔ se convierte en la primera empr...

by EY - Ernst & Young

tuTECHÔ, empresa social que lucha contra el sinhogarismo en España, ...

Photos Stream